* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 19Dementias
Neurobiological effects of physical exercise wikipedia , lookup
Cognitive neuroscience of music wikipedia , lookup
Cognitive neuroscience wikipedia , lookup
Executive functions wikipedia , lookup
Limbic system wikipedia , lookup
Holonomic brain theory wikipedia , lookup
Molecular neuroscience wikipedia , lookup
Externalizing disorders wikipedia , lookup
Perivascular space wikipedia , lookup
Neurogenomics wikipedia , lookup
State-dependent memory wikipedia , lookup
Environmental enrichment wikipedia , lookup
Memory and aging wikipedia , lookup
De novo protein synthesis theory of memory formation wikipedia , lookup
Executive dysfunction wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Reconstructive memory wikipedia , lookup
Aging brain wikipedia , lookup
Visual selective attention in dementia wikipedia , lookup
Impact of health on intelligence wikipedia , lookup
Nutrition and cognition wikipedia , lookup
Parkinson's disease wikipedia , lookup
Alzheimer's disease wikipedia , lookup
Biochemistry of Alzheimer's disease wikipedia , lookup
Dementias PSYC4080 6.0D Dementias 1 Neurodegenerative Disorders A varied assortment of central nervous system disorders characterized by gradual and progressive loss of neural tissue. Examples: Alzheimer’s, Parkinson’s, Multiple Sclerosis, dementia with Lewy bodies, multiple system atrophy Disorders can affect anyone at any age, not just a disease in the elderly • Can even strike during infancy PSYC4080 6.0D Dementias 2 Incidence, Prevalence Usually a disease of aging populations Highest prevalence over age 85. Can occur in children and adolescents, and shown as a deterioration in function. Estimates (Census, 2001) • 3% in adults 20-70 • 10% 70-85 • 20% over 85 years 10% genetic concordance (Sherrington, 1995) PSYC4080 6.0D Dementias 3 Prevalence Parkinson’s: 8-15 in 100,000 (0.000080.00015%) Alzheimer’s: 435,000 persons over 65 years (0.01%) PSYC4080 6.0D Dementias 4 Neuropathology Protein Degeneration (Cummings, 2003) Abnormalities in the metabolism of three proteins account for more than 90% of all neurodegenerative dementias misfolded proteins that cannot be properly degraded within affected cells Amyloid-beta, alpha-synuclein, and tau 1. Binding along the membrane 2. Accumulation of these proteins 3. Abnormal cellular maintenance PSYC4080 6.0D Dementias 5 Protein Degeneration All of these proteins are involved with maintaining the structure and integrity of neurons 1. Amyloid-beta: regulation of synaptic strength 2. Alpha-synuclein: integrity of vesicles containing neurotransmitter • DA neurons may be selectively vulnerable to toxic effects 3. Tau: microtubule assembly and stabilization Dysregulation contributes to cell death PSYC4080 6.0D Dementias 6 Protein Degeneration Accumulation of these proteins often begins in brainstem (substantia nigra, locus coeruleus) Work their way to limbic and (frontal, temporal) cortical areas Producing characteristic cell death and subsequent affects and memory and executive functioning. PSYC4080 6.0D Dementias 7 Protein Degeneration www.alzheimer.ca PSYC4080 6.0D Dementias 8 Neuropathology A. Frontal lobe dysfunction/dementias Degeneration of neurons in the frontal lobe, basal ganglia Interruption of frontal-subcortical pathways Deficits similar to those of frontal lobe lesion patients. PSYC4080 6.0D Dementias 9 Neuropathology Symptoms of dementia (DSM-IV) 1. Aphasia (language disturbance). 2. Apraxia (impaired ability to carry out motor activities despite intact motor function). 3. Agnosia (failure to recognize or identify objects despite intact sensory function). PSYC4080 6.0D Dementias 10 Neuropathology Symptoms of dementia (DSM-IV) 4. Executive functioning Planning, organizing, sequencing, abstracting Working memory Encoding new memories Episodic memories 5. Delusions or hallucinations PSYC4080 6.0D Dementias 11 Neuropathology B. Mood disturbances Major depressive disorder common Correlated to executive functioning deficits, implying further frontal lobe effects Evidence that the severity of executive and mood disorders directly related to the volume of cortex destroyed PSYC4080 6.0D Dementias 12 Parkinson’s Disease Assessment by a neuropsychologist is always undertaken in these cases 1. assessment of recall and recognition memory 2. assessment of long term memories 3. short-term memory 4. cued versus uncued recall 5. word naming for language function 6. testing for apraxia 7. visuospatial functioning 8. executive functioning PSYC4080 6.0D Dementias 13 Parkinson’s Disease Cognitive Deficits 1. Disorders of executive function: generating, maintaining, shifting, and blending of sets characterize executive-function disorders, (mental inflexibility) decreased generation and maintenance of sets and slowness in shifting sets in new situations. no impairment when performing overlearned tasks benefit from external cues and structure. difficulty with novel stimuli. PSYC4080 6.0D Dementias 14 Parkinson’s Disease Cognitive Deficits 2. Visuospatial difficulties: line orientation, block design, and picture arrangement, non–familiarface discrimination (IQ subtests). present even when motor impairment is absent. PSYC4080 6.0D Dementias 15 Parkinson’s Disease Cognitive Deficits 3. Memory deficits: retrieval deficits in immediateand long-term memory impairment, abnormalities in procedural memory, (includes anterograde and retrograde amnesias) Providing patients with retrieval cues can improve memory performance Disproportionately impaired in their ability to temporally order or sequence new information PSYC4080 6.0D Dementias 16 Parkinson’s Disease Cognitive Deficits 4. Language abnormalities: naming and fluency, comprehending syntactically embedded questions. Their sentences tend to be grammatically simple. Deficits in speech production. 5. Full blown dementia: Disturbance in executive function is the most common; apraxia and agnosia rarely occur. PSYC4080 6.0D Dementias 17 Parkinson’s Disease A neuropsychiatrist need only be involved when: 1. risk-taking behaviours increase as disease progresses. 2. violent behaviour 3. disinhibited behaviours 4. delusions of persecution 5. hallucinations 6. exaggerated responses to stress PSYC4080 6.0D Dementias 18 Alzheimer’s Dementia Confirmed only though postmortem studies Poor relation between neurobiological changes and clinical symptoms Diagnosis is based on the general symptoms of dementia, not on imaging data. Scale of Behavioural Change used to determine stages (Reisburg, 1983) • From Very Mild to Very Severe PSYC4080 6.0D Dementias 19 Alzheimer’s Dementia Degree of Cognitive Decline None Very mild PSYC4080 6.0D Symptoms No subjective complaints of memory deficits. No memory deficits noted on testing Complaints of memory deficit: 1) forgetting where one has placed familiar objects, or 2) forgetting names that once knew well No objective evidence of memory problem on interview No objective deficits in employment or social situations Appropriate concern with respect to symptomatology Dementias 20 Alzheimer’s Dementia Degree of Cognitive Decline Very severe PSYC4080 6.0D Symptoms All verbal abilities are lost. Often no speech at all, only grunting. Incontinent of urine Require assitance in toileting and feeding. Losses basic motor skills (ability to walk) Brain and body are disconnected. Dementias 21 Alzheimer’s Neuropathology Still mainly confirmed through postmortem findings (Selkoe, 1992; Brun, 1983) • neuropathology non-specific to Alzheimer’s Neuritic plaques - found in cerebral cortex, and correlated with degree of cognitive dysfunction (amyloid-beta peptide) Neurofibrillary tangles in the neurons, especially hippocampus (helical fragments) Loss of cortical volume typically in temporal areas, limbic cortex, posterior parietal areas. PSYC4080 6.0D Dementias 22 Alzheimer’s Neurobiology Loss of cells in entorhinal cortex (main input into the hippocampus) Loss of dendrites General decrease in neurotransmitters: NA, DA, 5HT, glutamate Similar findings have been suggested for other types of dementias PSYC4080 6.0D Dementias 23 Lewy Bodies Dementia Neurodegenerative disorder associated with abnormal structures (Lewy bodies) found in certain areas of the brain. Associated with Parkinson's and Alzheimer's diseases Researchers not sure whether it’s a distinct clinical entity or a variant of Alzheimer's or Parkinson's disease. Quite common: 10-25% of all dementia cases PSYC4080 6.0D Dementias 24 Lewy Bodies Dementia Appear as toxic dark red or brown spots in the cytoplasm of the neuron, typically in substantia nigra. DA neurons may be selectively vulnerable to toxic effects Contain the protein alpha-synuclein, which normally maintains integrity of vesicles containing neurotransmitter PSYC4080 6.0D Dementias 25 Other Information Generally speaking, the severity of neuropsychological dysfunction (dementia and mood) is correlated to the extent of brain atrophy • More related to brain volume than to effects on a particular brain area. The cause of neurodegenerative disorders is unknown Still some debate as to whether Alzheimer’s is a disease at all PSYC4080 6.0D Dementias 26 Other Information Typically dementias are not reversible but follow a progressive or static course Reversible only if caused by a treatable general medical condition (e.g. hypoglycemia) Ultimately, dementias lead to death (related to mobility) 1. increased incidence of accidents 2. increased susceptibility to infections PSYC4080 6.0D Dementias 27 The problem of treatment Antiparkinsonian (DA) medication may actually worsen such symptoms as hallucinations and delusions. Neuroleptic (antipsychotic) drugs prescribed for psychiatric symptoms may markedly worsen the movement symptoms (DA antagonist, among other things). Which symptoms to treat, or can both movement and psychiatric conditions be addressed? PSYC4080 6.0D Dementias 28